Effect of storage at -70 degrees C on immunoturbidimetric assays for apolipoproteins A-I and B. 1994

A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
Foundation for Blood Research, Scarborough, ME 04074-0190, USA.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D009391 Nephelometry and Turbidimetry Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam. Turbidimetry,Nephelometry,Turbidimetry and Nephelometry
D005615 Freezing Liquids transforming into solids by the removal of heat. Melting
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001055 Apolipoproteins B Major structural proteins of triacylglycerol-rich LIPOPROTEINS. There are two forms, apolipoprotein B-100 and apolipoprotein B-48, both derived from a single gene. ApoB-100 expressed in the liver is found in low-density lipoproteins (LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL). ApoB-48 expressed in the intestine is found in CHYLOMICRONS. They are important in the biosynthesis, transport, and metabolism of triacylglycerol-rich lipoproteins. Plasma Apo-B levels are high in atherosclerotic patients but non-detectable in ABETALIPOPROTEINEMIA. Apo-B,Apo B,ApoB,Apoprotein (B),Apoproteins B
D013696 Temperature The property of objects that determines the direction of heat flow when they are placed in direct thermal contact. The temperature is the energy of microscopic motions (vibrational and translational) of the particles of atoms. Temperatures
D016632 Apolipoprotein A-I The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE. Apo A-I,Apo A-1,Apo A-I Isoproteins,Apo A1,Apo AI,ApoA-1,ApoA-I,Apolipoprotein A-1,Apolipoprotein A-I Isoprotein-2,Apolipoprotein A-I Isoprotein-4,Apolipoprotein A-I Isoproteins,Apolipoprotein A1,Apolipoprotein AI,Apolipoprotein AI Propeptide,Pro-Apo A-I,Pro-Apolipoprotein A-I,Proapolipoprotein AI,Apo A I Isoproteins,Apolipoprotein A 1,Apolipoprotein A I,Apolipoprotein A I Isoprotein 2,Apolipoprotein A I Isoprotein 4,Apolipoprotein A I Isoproteins,Pro Apo A I,Pro Apolipoprotein A I

Related Publications

A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
June 1986, Clinical chemistry,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
May 1991, Clinical chemistry,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
February 1997, Clinica chimica acta; international journal of clinical chemistry,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
September 1994, Clinical chemistry,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
June 1993, Recenti progressi in medicina,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
April 1988, Journal of clinical pathology,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
January 1999, Annals of the Academy of Medicine, Singapore,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
May 2009, Thrombosis research,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
October 1984, Journal of clinical pathology,
A M Johnson, and T B Ledue, and G E Palomaki, and W Y Craig
January 1986, Zeitschrift fur medizinische Laboratoriumsdiagnostik,
Copied contents to your clipboard!